You are here: Home » PTI Stories » National » News
Business Standard

Suven Life up 5% on getting patent for neuro degenerative drug

Press Trust of India  |  New Delhi 

Shares of rose over 5 per cent today as the company has been granted one product patent each by and for a drug used in the treatment of neuro-degenerative diseases.

The stock gained 5.22 per cent to Rs 204.30 on

At NSE, shares of the company went up 5.27 per cent to Rs 204.50.

The company has been granted "one product patent from and one product patent from corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with neuro-degenerative diseases," it said in a filing today.

The patents are valid through 2030 and 2029 respectively, the company added.

With these new patents, Suven has a total of 23 patent from and 12 from

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, October 18 2016. 13:02 IST